Increased surface toll-like receptor 2 expression in superantigen shock
Authors:
- Alison C. PridmoreAPAlison C. Pridmore
- Stephan EllmerichSEStephan Ellmerich
- John D. FraserJFJohn D. Fraser
- Hugh H. RussellHRHugh H. Russell
- Robert C. ReadRRRobert C. Read
- Shiranee SriskandanSSShiranee Sriskandan
- 1 April 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 36 (4) , 1267-1276
Abstract
Examination of the interaction between gram-positive bacterial superantigens and toll-like receptor 2 (TLR2) in health and critical illness. Laboratory ex vivo model and prospective clinical, cohort study. Two research laboratories in university hospitals and two intensive care units. Laboratory study was performed in transfected HeLa cells and primary human monocytes from healthy volunteers. Clinical study used cells from 20 healthy controls and 45 critically ill patients with circulatory shock. HeLa cells and purified monocytes were exposed to purified superantigens or isogenic bacterial supernatants and readout obtained by cytokine enzyme-linked immunosorbent assay, flow cytometry, and quantitative real-time polymerase chain reaction. Peripheral blood mononuclear cells from patients with circulatory shock were compared with controls using flow cytometry and measurement of cytokines after ligand exposure. Superantigens were unable to signal through ligation by TLR2. However, TLR2 was up-regulated on the surface of primary human monocytes, without detectable TLR2 messenger RNA neosynthesis, by a range of superantigens and superantigen-containing Streptococcus pyogenes supernatants, although not by isogenic superantigen-negative strains. Superantigen mutant constructs with disrupted major histocompatibility complex class II-binding sites did not support TLR2 up-regulation. TLR2 up-regulation was associated with an increase in the proinflammatory response to TLR2 ligands only at high ligand concentrations. TLR2 was up-regulated in a small subset of patients with severe S. pyogenes sepsis but not in patients with any other category of septic or circulatory shock; responses to TLR2 ligands were reduced in all categories of critically ill patient, however. Superantigens up-regulate monocyte surface TLR2 expression through major histocompatibility complex class II signaling. Enhanced surface TLR2 expression may be a specific feature of patients with S. pyogenes-induced shock. Importantly, intensity of TLR2 signaling is not necessarily coupled to TLR2 expression when ligand concentrations are low or after onset of critical illness.Keywords
This publication has 49 references indexed in Scilit:
- Streptococcus pyogenes: Insight into the function of the streptococcal superantigensThe International Journal of Biochemistry & Cell Biology, 2007
- Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammationJournal of Antimicrobial Chemotherapy, 2006
- Immune evasion by staphylococciNature Reviews Microbiology, 2005
- Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los AngelesNew England Journal of Medicine, 2005
- Purpura Fulminans Due toStaphylococcus aureusClinical Infectious Diseases, 2005
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens*Critical Care Medicine, 2003
- Mechanism of Gram-positive Shock: Identification of Peptidoglycan and Lipoteichoic Acid Moieties Essential in the Induction of Nitric Oxide Synthase, Shock, and Multiple Organ FailureJournal of Experimental Medicine, 1998
- T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.Journal of Experimental Medicine, 1992
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989